AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lariglim M 1mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Larizona Pharmaceutical Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Lariglim M 1mg/500mg Tablet PR

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's one component of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintain regular mealtimes and carry a readily available glucose source, such as sweets or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any prior heart conditions before initiating treatment; it may not be appropriate for you. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function will be necessary under your doctor's guidance.

Uses of Lariglim M 1mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Lariglim M 1mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for dosage guidance prior to administration. Consume Lariglim M 1mg/500mg Tablet PR with food.

Common Side effects of Lariglim M 1mg/500mg Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Lariglim M 1mg/500mg Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Lariglim M 1mg/500mg Tablet PR with a meal.

How Lariglim M 1mg/500mg Tablet PR works:

Lariglim M 1mg/500mg tablets are a dual-action antidiabetic formulation combining glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Lariglim M 1mg/500mg Tablet PR ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Lariglim M 1mg/500mg Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding is contraindicated while using Lariglim M 1mg/500mg tablets. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Lariglim M 1mg/500mg Tablet PR, as dosage modification may be necessary. Individuals with severe kidney disease should avoid this medication. Physician consultation is recommended. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Lariglim M 1mg/500mg Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in severe hepatic dysfunction.

What if you forget to take Lariglim M 1mg/500mg Tablet PR :

Should you forget a dose of Lariglim M 1mg/500mg Tablet PR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lariglim M 1mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Lariglim M 1mg/500mg Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Lariglim M 1mg/500mg Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. If you experience these, discontinue Lariglim M 1mg/500mg Tablet PR and seek immediate medical attention.
Lariglim M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 diabetes.
Lariglim M 1mg/500mg Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Long-term use of Lariglim M 1mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Lariglim M 1mg/500mg Tablet PR can indeed cause low blood sugar (hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Lariglim M 1mg/500mg tablets with alcohol is unsafe. Alcohol can worsen the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Lariglim M 1mg/500mg Tabl...
41
MRP 50
17% off